MIR4671

Across TCGA pan-cancer cohorts, MIR4671 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated MIR4671 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MIR4671 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4671 expression acts as an unfavorable survival marker, although some lineages such as UCS and BRCA show a favorable association.

MESO, STAD, and TGCT are the cancer types where MIR4671 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	IV	0.056	0.640	<.001	102	view →
STAD	DFS	Tertile	All	0.490	0.682	<.001	102	view →
TGCT	DFS	Tertile	All	0.346	0.779	<.001	90	view →
UCS	DFS	Tertile	III,IV	0.649	0.166	.005	90	view →
KIRP	OS	Tertile	All	0.735	0.936	.006	39	view →
KIRC	DFS	Tertile	All	0.479	0.675	.005	26	view →
THCA	OS	Tertile	All	0.770	0.985	.003	22	view →
BRCA	DFS	Tertile	III,IV	0.915	0.758	.004	21	view →
COAD	OS	Tertile	III,IV	0.163	0.791	.004	18	view →
CESC	DFS	Tertile	All	0.687	0.840	.005	18	view →
OV	OS	Tertile	III,IV	0.249	0.338	.021	18	view →
HNSC	DFS	Tertile	III,IV	0.315	0.543	.020	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

MIR4671–MESO (OS)

Open the MESO breakdown →